The study — published recently in the journal Social Science & Medicine — identified three key high school factors linked to ...

In the past 20 years, the average rate of obesity among adults in the United States has risen by approximately 30%, but the ...

Between 1990 and 2017 the global deaths attributed to high body mass index more than doubled from 2.2 million to 4.7 million ...

From obesity-related risks to navigating public shame, here’s a deeper look into how society polices Black women’s pregnant ...

"His insight, wisdom, and thoughts on the future of our great country are always so inspiring. His pat on the back is a great ...

There are over 1 billion obese people in the world, according to research published in The Lancet. A network of 1,500 ...

Photo shows New Year's Weather: Dark grey storm clouds over a green forested area, with a rain storm on the horizon.

Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 years. The headline-grabbing change is that experts now say ...

Pfizer plans to explore other obesity treatments for testing. Pfizer is halting the development of its potential pill for treating obesity following an injury that happened during a clinical trial.

Background: Obesity is a complex, chronic, stigmatized disease whereby abnormal or excess body fat may impair health or increase the risk of medical complications, and can reduce quality of life and ...

Pfizer will stop developing an obesity pill that has been closely watched ... The shares were down about 1% in premarket trading at 7:07 a.m. in New York. Rivals’ shares advanced, with Novo ...